You searched for "botulinum toxin"
Croma-Pharma completed the decentralized procedure for its botulinum toxin to treat glabellar (frown) lines
Croma’s botulinum toxin submission in Europe is based on the data of 3 completed randomized, placebo-controlled phase III trials that enrolled a total of >1000 subjects in Europe and the US.What’s new on the horizon for toxins coming to the market?
With the ever increasing demand for injectable treatments, it is important to keep abreast of new developments in the field. International expert Michael Gold reviews the new toxins due to be hitting the market in the next year. We are...Higher dose neurotoxins – what’s new?
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. How can we achieve longer lasting results with neurotoxins? With a new...
